<DOC>
	<DOCNO>NCT02044809</DOCNO>
	<brief_summary>The purpose trial investigate novel treatment cannabis dependence : cannabidiol . Between 96 168 young people want quit cannabis meet criterion moderate cannabis use disorder ( DSM-5 ) recruit community . Stage one aim identify Most Effective Dose ( MEDmg ) oral cannabidiol reduce cannabis use four treatment week . Stage two determine whether MED identify stage 1 offer effective treatment cannabis dependence .</brief_summary>
	<brief_title>Cannabidiol : Novel Intervention Cannabis Use Problems ?</brief_title>
	<detailed_description />
	<mesh_term>Marijuana Abuse</mesh_term>
	<criteria>Aged 16 60 year old . Meet DSM5 criterion moderate cannabis use disorder ( ≥4 DSM5 criterion ) Express desire quit use cannabis within next four week , Have ≥1 previous fail quit attempt . Smoke tobacco cannabis , Test positive recent cannabis use accord urine analysis , Vital sign within healthy limit capacity give consent Not willing use effective contraception consent take 6 week treatment stop Positive pregnancy test breastfeeding Allergies Investigational Medicinal Product ( IMP ) placebo excipients &gt; twice/month use illicit drug Outside normal Body Mass Index ( BMI ) A physical health problem deem clinically significant The use current prescribe psychotropic drug Current prior selfreported diagnosis psychotic disorder NonEnglish speaker due verbal assessment .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>